Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis

Author:

Alexander Emma C1,Faruqi Duaa2,Farquhar Robert2,Unadkat Ayesha2,Ng Yin Kyla1ORCID,Hoskyns Rebecca1,Varughese Rachel3,Howard Sasha R14ORCID

Affiliation:

1. Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London EC1M 6BQ , United Kingdom

2. Faculty of Life Sciences and Medicine, King’s College London, Guy’s Campus , London SE1 1UL , United Kingdom

3. Department of Paediatric Endocrinology, Great Ormond Street Hospital NHS Trust , London WC1N 3JH , United Kingdom

4. Department of Paediatric Endocrinology, Royal London Children’s Hospital, Barts Health NHS Trust , London E1 1BB , United Kingdom

Abstract

Abstract Objective Hypogonadotropic hypogonadism is characterized by inadequate secretion of pituitary gonadotropins, leading to absent, partial, or arrested puberty. In males, classical treatment with testosterone promotes virilization but not testicular growth or spermatogenesis. To quantify treatment practices and efficacy, we systematically reviewed all studies investigating gonadotropins for the achievement of pubertal outcomes in males with hypogonadotropic hypogonadism. Design Systematic review and meta-analysis. Methods A systematic review of Medline, Embase, Global Health, and PsycINFO databases in December 2022. Risk of Bias 2.0/Risk Of Bias In Non-randomized Studies of Interventions/National Heart, Lung, and Blood Institute tools for quality appraisal. Protocol registered on PROSPERO (CRD42022381713). Results After screening 3925 abstracts, 103 studies were identified including 5328 patients from 21 countries. The average age of participants was <25 years in 45.6% (n = 47) of studies. Studies utilized human chorionic gonadotropin (hCG) (n = 93, 90.3% of studies), human menopausal gonadotropin (n = 42, 40.8%), follicle-stimulating hormone (FSH) (n = 37, 35.9%), and gonadotropin-releasing hormone (28.2% n = 29). The median reported duration of treatment/follow-up was 18 months (interquartile range 10.5-24 months). Gonadotropins induced significant increases in testicular volume, penile size, and testosterone in over 98% of analyses. Spermatogenesis rates were higher with hCG + FSH (86%, 95% confidence interval [CI] 82%-91%) as compared with hCG alone (40%, 95% CI 25%-56%). However, study heterogeneity and treatment variability were high. Conclusions This systematic review provides convincing evidence of the efficacy of gonadotropins for pubertal induction. However, there remains substantial heterogeneity in treatment choice, dose, duration, and outcomes assessed. Formal guidelines and randomized studies are needed.

Funder

NIHR Academic Clinical Fellowship

NIHR

NHS

UK Department of Health and Social Care

Wellcome Trust

Barts Charity

Publisher

Oxford University Press (OUP)

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference90 articles.

1. Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center;Varimo;Hum Reprod.,2017

2. Congenital hypogonadotrophic hypogonadism: minipuberty and the case for neonatal diagnosis;Swee;Front Endocrinol (Lausanne).,2019

3. Kallmann syndrome;Dodé;Eur J Hum Genet.,2009

4. Male acquired hypogonadotropic hypogonadism: diagnosis and treatment;Salenave;Ann Endocrinol (Paris).,2012

5. Minipuberty: why does it happen?;Becker;Horm Res Paediatr.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3